141 related articles for article (PubMed ID: 10320912)
41. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
42. Papillary serous carcinoma of the peritoneum with paraaortic lymph node metastasis despite minimal intraperitoneal involvement: a case report.
Komiyama S; Asai S; Dokoh J; Tsuji H; Ishikawa M; Mikami M
Acta Cytol; 2006; 50(3):323-6. PubMed ID: 16780029
[TBL] [Abstract][Full Text] [Related]
43. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
44. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
Bristow RE; Duska LR; Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
[TBL] [Abstract][Full Text] [Related]
45. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
46. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
47. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
[TBL] [Abstract][Full Text] [Related]
48. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
[TBL] [Abstract][Full Text] [Related]
49. Paratesticular papillary serous cystadenocarcinoma: a rare entity in Indian population.
Narang V; Sood N; Garg B; Aulakh BS
Indian J Pathol Microbiol; 2014; 57(4):614-6. PubMed ID: 25308020
[TBL] [Abstract][Full Text] [Related]
50. A primary mesothelioma involving the rectovaginal septum and associated with beryllium.
Gold C
J Pathol Bacteriol; 1967 Apr; 93(2):435-42. PubMed ID: 6054052
[No Abstract] [Full Text] [Related]
51. An inconspicuous fallopian-tube carcinoma clinically manifested as a rectovaginal septal tumor: a pitfall for diagnosis and treatment.
Asai-Sato M; Hayashi H; Miyagi Y; Takahashi M; Shigeta H
Int J Clin Oncol; 2011 Apr; 16(2):161-4. PubMed ID: 20734099
[TBL] [Abstract][Full Text] [Related]
52. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
[TBL] [Abstract][Full Text] [Related]
53. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
54. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
Zighelboim I; Broaddus R; Ramirez PT
Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
[TBL] [Abstract][Full Text] [Related]
55. [Serous-papillary adenocarcinoma with Müllerian neoplasia after prophylactic ovariectomy].
Kaltenegger A; Stieglbauer W; Veith C; Hartmann B
Gynakol Geburtshilfliche Rundsch; 2002; 42(3):158-60. PubMed ID: 12169786
[TBL] [Abstract][Full Text] [Related]
56. Multicentric transitional cell carcinoma of the vagina and the ureter.
Hermanova M; Vitezslav V; Husicka R; Neumanova R; Pacik D
Ann Diagn Pathol; 2008 Oct; 12(5):365-7. PubMed ID: 18774501
[TBL] [Abstract][Full Text] [Related]
57. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
[TBL] [Abstract][Full Text] [Related]
58. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
59. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study.
Markaki S; Protopapas A; Milingos S; Lazaris D; Antsaklis A; Michalas S
Gynecol Oncol; 2005 Mar; 96(3):860-4. PubMed ID: 15721439
[TBL] [Abstract][Full Text] [Related]
60. Carcinoma of the recto-vaginal septum. Comprehensive literature review.
Lopez N; Grabowski JP; De Santiago J; Zapardiel I
J Obstet Gynaecol; 2016 May; 36(4):450-4. PubMed ID: 26467428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
